Grainne Quinn
Chief Tech/Sci/R&D Officer en PERRIGO COMPANY PLC .
Fortuna: 678 501 $ al 31/03/2024
Perfil
En la actualidad, Grainne Quinn ocupa el cargo de directora médica y vicepresidenta ejecutiva en Perrigo Co. Plc. Anteriormente, la Dra. Quinn ocupó el cargo de Directora Médica de Elan Corp. Plc. La Dra. Quinn se doctoró en el Royal College of Surgeons.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
PERRIGO CO. PLC
0.02% | 05/04/2024 | 21 078 ( 0.02% ) | 678 501 $ | 31/03/2024 |
Cargos activos de Grainne Quinn
| Empresas | Cargo | Inicio |
|---|---|---|
| PERRIGO COMPANY PLC | Chief Tech/Sci/R&D Officer | 01/11/2015 |
Antiguos cargos conocidos de Grainne Quinn.
| Empresas | Cargo | Fin |
|---|---|---|
Elan Corp. Plc
 Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Elan Corp. Plc is a neuroscience focused biotechnology company. The company engages in research, development, and commercial activities for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease and autoimmune diseases, including multiple sclerosis. It was founded in December 1969 and is headquartered in Dublin, Ireland. | Chief Tech/Sci/R&D Officer | 01/12/2013 |
Formación de Grainne Quinn.
| Royal College of Surgeons | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| PERRIGO COMPANY PLC | Health Technology |
| Empresas privadas | 1 |
|---|---|
Elan Corp. Plc
Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Elan Corp. Plc is a neuroscience focused biotechnology company. The company engages in research, development, and commercial activities for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease and autoimmune diseases, including multiple sclerosis. It was founded in December 1969 and is headquartered in Dublin, Ireland. | Health Technology |
- Bolsa de valores
- Insiders
- Grainne Quinn
